Science Explorer Back to mapMap
Discussion
Topic · General Social Sciences

HIV, TB, and STIs Epidemiology

HIV, TB, and STIs Epidemiology is a research topic within General Social Sciences. Science Explorer counts 2.4k research works in it since 1950. 10.1% of them reached the world's top 10% most cited for their field and year.

This cluster of papers covers a wide range of topics in social science and humanities research, including globalization, cultural identity, power dynamics, political ideologies, historical analysis, democracy, migration, education, and health. The papers delve into the complexities of societal structures, human behavior, and the impact of various factors on individuals and communities.

  • Globalization
  • Identity
  • Power
  • Politics
  • Cultural
  • History
  • Democracy
  • Migration
  • Education
  • Health
Research works
2.4k
fractional, since 1950
In the world top 10%
245
per year above
Top-10% rate
10.1%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-27%
the tick is no change
Largest producer
Russia
42% of the 10 largest, 2022-now
HIV, TB, and STIs Epidemiology

Which countries lead HIV, TB, and STIs Epidemiology research?

By volume, Russia and the United States publish the most (139 and 41 works in 2022-now).

By volume, 2022-now

  1. 1 Russia 139 works
  2. 2 United States 41 works
  3. 3 Ukraine 28 works
  4. 4 Indonesia 27 works
  5. 5 China 22 works
  6. 6 Uzbekistan 18 works
  7. 7 India 15 works
  8. 8 Netherlands 15 works
  9. 9 United Kingdom 15 works
  10. 10 Brazil 8 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

Russia: 42.4%United States: 12.4%Ukraine: 8.6%Indonesia: 8.3%6 others listed: 28.3%42%largest
Russia139 · 42.4%United States41 · 12.4%Ukraine28 · 8.6%Indonesia27 · 8.3%6 others listed93 · 28.3%

Shares of the rows listed above, not of the whole node.

Which institutions lead HIV, TB, and STIs Epidemiology research?

By volume in 2022-now, Russian Academy of Sciences publishes the most HIV, TB, and STIs Epidemiology research, followed by Regional Center for Prevention and Control of AIDS and Infectious Diseases and First Pavlov State Medical University of St. Petersburg.

By volume, 2022-now

  1. 1 Russian Academy of SciencesRussia 10 works
  2. 2 Regional Center for Prevention and Control of AIDS and Infectious DiseasesRussia 9 works
  3. 3 First Pavlov State Medical University of St. PetersburgRussia 6 works
  4. 4 Irkutsk State Medical UniversityRussia 5 works
  5. 5 Ministry of Health of the Russian FederationRussia 5 works
  6. 6 Shupyk National Healthcare University of UkraineUkraine 4 works
  7. 7 Sechenov UniversityRussia 4 works
  8. 8 State Research Center for Dermatovenereology and CosmetologyRussia 3 works
  9. 9 Odessa National Medical UniversityUkraine 3 works
  10. 10 Kyrgyz State Medical AcademyKyrgyzstan 3 works

Who are the leading researchers in HIV, TB, and STIs Epidemiology?

The most-cited researchers publishing on HIV, TB, and STIs Epidemiology include Jun Wang and Maarten Jacobus Postma.

  1. 1 Jun Wang China 340k citations
  2. 2 Maarten Jacobus Postma Netherlands 156k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in HIV, TB, and STIs Epidemiology?

The most cited paper in HIV, TB, and STIs Epidemiology is "Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease" (Florence Portet, 2006), with 663 citations. Next come "Immunopathogenic Mechanisms of HIV Infection" (514) and "Syphilis" (452).

Most cited papers
#PaperReleasedCitations
1 Mild cognitive impairment (MCI) in medical practice: a critical review of the concept and new diagnostic procedure. Report of the MCI Working Group of the European Consortium on Alzheimer's Disease Florence Portet · Journal of Neurology Neurosurgery & Psychiatry Open access 20 Mar 2006 663
2 Immunopathogenic Mechanisms of HIV Infection Anthony S. Fauci, Giuseppe Pantaleo, Sharilyn Stanley et al. · Annals of Internal Medicine Apr 1996 514
3 Syphilis Edward W. Hook · The Lancet 18 Dec 2016 452
4 2020 European guideline on the management of syphilis Marc F Janier, Magnus Unemo, Nicolas Dupin et al. · Journal of the European Academy of Dermatology and Venereology 22 Oct 2020 411
5 Transition in Specification of Embryonic Metazoan DNA Replication Origins Olivier Hyrien, Chrystelle Antoinat Maric, Marcel Méchali · Science 10 Nov 1995 325
All 100 most cited papers, with filters and sorting

Where is HIV, TB, and STIs Epidemiology research done?

The largest centres of HIV, TB, and STIs Epidemiology research in 2022-now are Moscow (Russia), Saint Petersburg (Russia), Nizhny Novgorod (Russia) and Tashkent (Uzbekistan). Among places with at least 20 works in it, it is an unusually large share of all research in Moscow.

Largest cities, 2022-now

  1. 1 MoscowRussia 41 works
  2. 2 Saint PetersburgRussia 19 works
  3. 3 Nizhny NovgorodRussia 16 works
  4. 4 TashkentUzbekistan 10 works
  5. 5 KyivUkraine 9 works
  6. 6 IrkutskRussia 9 works
  7. 7 YekaterinburgRussia 7 works
  8. 8 NovosibirskRussia 6 works
  9. 9 LondonUnited Kingdom 6 works
  10. 10 BeijingChina 5 works

Where it is the local speciality

  1. MoscowRU · 40.8 works9.2×
← less than its size predicts1×more →

Location quotient: how much more of its research is in HIV, TB, and STIs Epidemiology than the world average.

See HIV, TB, and STIs Epidemiology on the map

Is HIV, TB, and STIs Epidemiology research growing?

Output in 2022-2025 was 27% lower than in 2018-2021, peaking in 2019.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is HIV, TB, and STIs Epidemiology as a percentage of every work published that year, 0.0013% in 2024.

still counting0.0020%0.0040%HIV, TB, and STIs Epidemiology0.0019% in 202519801990200020102020

Fractional works of HIV, TB, and STIs Epidemiology over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%HIV, TB, and STIs Epidemiology10.9% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about HIV, TB, and STIs Epidemiology. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.